Why Should You Attend:
Cannabis industry can learn from a well-established pharmaceutical to develop a successful product with optimized formulation and subsequently longer shelf-life. This workshop will utilize presenter’s 20+ years’ experience in leading various pharmaceutical and cannabis companies research and development’s teams. The Goal of this workshop is to provide participants with concepts, tips and tricks of things to do and not to do for a successful quick product development to either enter recreational market or quick ANDA submission to FDA or other regulatory agencies.
We will explore risk-based evaluation of product quality and impact of excipients
Concept and application of quality by design including critical material attributes (CMA) and critical process parameters (CPP). Planning for excipient-cannabinoids compatibility will be explored in a generic format expandable to specific applications.
Various oral dosage forms will be reviewed including capsules, gummies, emulsions and tables. Fill and shell formulation and compatibility for capsules will be explored with discussing various types of fill formulations.
The following questions will also be answered: What is the role of excipient in a formulation? What is the relationship between Dissolution/disintegration and bioavailability of cannabinoids? What are different scenarios for release of cannabinoids?
As part of this workshop, literature review, quality target product profile (QTPP) and concept of Quality Attributes (CQA) will be linked to proof-of-concept, i.e., bench work and comparable properties of product such as dissolution and disintegration.
Areas Covered in the Webinar:
Who Will Benefit:
From all industries, service and manufacturing companies working in cannabis and pharmaceuticals.Instructor Profile:
Dr. Harati is an expert and leader in pharmaceutical and cannabis industries with a broad research background and training in business administration that makes him able to quickly recognize challenges and provide clear, effective solutions. He has broad experience in research and development, product development, CMC product development, strategic planning and continuous improvement.
Dr. Harati is a high energy, tenacious leader that engages and inspires the team to own and execute the business plan with excellence. Over the past 20+ years, he has successfully led technical teams to develop novel products and analytical testing from discovery to commercialization. He facilitates fundamental product and process understanding and the advancement of innovative approaches to pharmaceuticals and cannabis development. Dr. Harati is author and presenter of more than 100 conferences, technical summaries, publications, funding white papers, and training guides.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction